Cover Image

A case of Malignant Bronchial Carcinoid- presenting as Unilateral hyperlucent lung

VIGNESH KUMAR K

Abstract


Bronchial Carcinoid Tumors (BCTs) belong to uncommon group of lung tumors. They
commonly affect young adults and the middle aged, the same age groups affected by other more
common chronic lung conditions such as pulmonary tuberculosis, COPD or bronchial asthma.
Diagnosis is commonly missed or delayed due to a low index of suspicion. Surgery is the mainstay of
treatment with an excellent outcome. We present a case of Malignant Bronchial Carcinoid Tumor
being treated as Bronchial Asthma for 4months, which later proved to be carcinoid tumor. On perusal
of previous records, CT chest showed unilateral hyper translucency with a suspicious opacity. Repeat
CT chest showed endobronchial mass with post obstructive pneumonitis. HPE following
endobronchial biopsy was suggestive of carcinoid tumor. Diagnosis was confirmed by
immunohistochemistry.

Full Text:

PDF

References


carcinoids. A higher level of chromogranin A is correlated with tumour burden.

Treatment

Surgery is the therapy of choice for carcinoid tumours, with parenchyma-sparing procedures

recommended for typical carcinoids(10). The aim is to remove the primary tumour and affected lymph

nodes radically, keeping as much of the lung parenchyma as possible. Endoscopic laser resection

also has a role, and this can be performed with a rigid or flexible bronchoscope(14). Because of the

many disadvantages of the rigid bronchoscope like need for general anaesthesia and more chance of

complications, however, most pulmonologists prefer a flexible bronchoscope for laser photoresection.

If complete surgical resection cannot be accomplished, or if metastatic disease is present,

chemotherapy and radiation therapy provide a little hope for cure. Metastatic or locally advanced

carcinoids display very poor responsiveness to a variety of chemotherapeutic regimens similar to

those utilised for treatment of small cell lung carcinoma, with a median overall survival of 20

months(15). Biotherapy with and interferon, octreotide, and lanreotide are mainly being attempted

for symptomatic relief.

Conclusion

Any patient presenting with localized wheeze and diagnosed as COPD or asthma, refractory to

medical treatment should be dealt with high suspicion. Warrants further investigation to confirm the

diagnosis with follow up chest radiographs, CT chests and bronchoscopy. Bronchial carcinoid tumors

should me considered in the differential diagnoses of such patients. Finally we conclude that ‘all that

wheezes are not asthma’ and more particularly when wheezes are localised.

References

Detterbeck FC. Management of carcinoid tumors. Ann Thorac Surg 2010;89:9981005.

Mancini MC, Jeffrey MC. Carcinoid Lung Tumors. Available from: http//www.

emedicine.medscape.com/article/426400overview.

Lips CJ, Lentjes EG, Höppener JW. The spectrum of carcinoid tumours and carcinoid

syndromes. Ann Clin Biochem. 2003;40(Pt 6):612–627.

Buck JL, Sobin LH. Carcinoids of the gastrointestinal tract. Radiographics

. 1990;10(6):1081–1095.

Fischer S, Kruger M, McRae K, Merchant N, Tsao MS, Keshavjee S. Giant bronchial carcinoid

tumors: A multidisciplinary approach. Ann Thorac Surg. 2001;71(1):386–393

Graham GW, Unger BP, Coursin DB. Perioperative management of selected endocrine

disorders. Int Anesthesiol Clin. 2000;38(4):31–67.]

Hamperl H. U¨ ber gutartige bronchialtumoren (cylindrome und carcinoid) Virchows Arch Pathol

Anat.1937;300:46–88.

Kulke MH, Mayer RJ. Carcinoid tumours. N Engl J Med. 1999;340(11):858–868.

Paladugu RR, Benfield JR, Pak HY, Ross RK, Teplitz RL. Bronchopulmonary kulchitzky cellcarcinomas: A new classification scheme for typical and atypical carcinoids. Cancer

. 1985;55(6):1303–1311.

Fink G, Krelbaum T, Yellin A, Bendayan D, Saute M, Glazer M, et al. Pulmonary carcinoidpresentation,

diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the

literature. Chest.2001;119(6):1647–1651.

Hage R, de la Riviere AB, Seldenrijk CA, van den Bosch JM. Update in pulmonary carcinoid

tumors: a review article. Ann Surg Oncol. 2003;10(6):697–704.

Rosado de Christenson ML, Abbott GF, Kirejczyk WM, Galvin JR, Travis WD. Thoracic

carcinoids: radiologic-pathologic correlation. Radiographics. 1999;19(3):707–736.

Morandi U, Casali C, Rossi G. Bronchial typical carcinoid tumors. Semin Thorac Cardiovasc Surg

.2006;18(3):191–198.

Rai SP, Patil AP, Vardhan V, Kumar R, Bhattacharya P, Pethe M. Intraluminal bronchial carcinoid

resection by bronchoscopy. MJAFI. 2008;64(1):86–88.

Granberg D, Eriksson B, Wilander E, Grimfjärd P, Fjällskog ML, Öberg K, et al. Experience in

treatment of metastatic pulmonary carcinoid tumors. Ann Oncol. 2001;12(10):1383–1391


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An initiative of The Tamil Nadu Dr M.G.R. Medical University